logo.gif
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
May 12, 2021 14:00 ET | Bavarian Nordic A/S
COPENHAGEN, Denmark, May 12, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has today received information about the following transactions of the Company’s shares/related securities by persons...
Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer
May 12, 2021 14:00 ET | Bavarian Nordic A/S
KØBENHAVN, Danmark, 12. maj 2021 - Bavarian Nordic A/S (OMX: BAVA) har dags dato modtaget oplysninger om følgende transaktioner med selskabets aktie/tilknyttede værdipapirer, foretaget af ledende...
logo.gif
U.S. Government Exercises Option for Supply of Additional Smallpox Vaccines from Bavarian Nordic
May 07, 2021 01:30 ET | Bavarian Nordic A/S
COPENHAGEN, Denmark, May 7, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the U.S. Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the...
Den amerikanske regering udnytter option på levering af yderligere koppevacciner fra Bavarian Nordic
May 07, 2021 01:30 ET | Bavarian Nordic A/S
KØBENHAVN, Danmark, 7. maj 2021 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at Biomedical Advanced Research and Development Authority (BARDA), en del af Office of the Assistant Secretary for...
logo.gif
Bavarian Nordic A/S - Articles of Association
May 03, 2021 04:48 ET | Bavarian Nordic A/S
Updated Articles of Association for Bavarian Nordic A/S. Attachment Bavarian Nordic - Articles of Association ...
Bavarian Nordic A/S - Vedtægter
May 03, 2021 04:48 ET | Bavarian Nordic A/S
Opdaterede vedtægter for Bavarian Nordic A/S. Vedhæftet fil Bavarian Nordic - Vedtægter ...
Bavarian Nordic Reports New Preclinical Data for COVID-19 Vaccine Confirming Potential for Broad Protection against SARS-CoV2 Variants
April 29, 2021 02:09 ET | Bavarian Nordic A/S
COPENHAGEN, Denmark, April 29, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today reported additional preclinical data for the capsid virus-like particle (cVLP) COVID-19 vaccine candidate,...
Bavarian Nordic rapporterer nye prækliniske resultater for COVID-19 vaccine, der bekræfter potentiale for bred beskyttelse mod SARS-CoV2-virusvarianter
April 29, 2021 02:09 ET | Bavarian Nordic A/S
KØBENHAVN, Danmark, 29. april 2021 – Bavarian Nordic A/S (OMX: BAVA) rapporterede i dag yderligere prækliniske resultater for COVID-19 vaccinekandidaten, ABNCoV2, som er baseret på en capsid virus...
logo.gif
Bavarian Nordic A/S – Report on the Results of the Annual General Meeting, held April 20, 2021
April 20, 2021 12:36 ET | Bavarian Nordic A/S
COPENHAGEN, Denmark, April 20, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today held the Annual General Meeting with the results as follows: The Annual Report for 2020 was adopted. The Board...
Bavarian Nordic A/S – Orientering om forløb af ordinær generalforsamling den 20. april 2021
April 20, 2021 12:36 ET | Bavarian Nordic A/S
KØBENHAVN, Danmark, 20. april 2021 – Bavarian Nordic A/S (OMX: BAVA) har i dag afholdt ordinær generalforsamling med følgende resultater: Årsrapporten for 2020 blev godkendt. Bestyrelsens forslag om,...